Elanco Q2 2026 Results: Raising Revenue & Adjusted EPS Guidance
Elanco Animal Health reported second quarter 2026 results with revenue growth, raising full-year guidance and improving its net leverage ratio target despite a reported net loss. This strengthens the company's position as a top performer in the animal health sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day